ENAD CADx has been designated as an Innovative Product by Korea’s Public Procurement Service (PPS).

Following ENAD’s designation in 2024, ENAD CADx has now also been recognized, reaffirming Ainex’s technological excellence and market competitiveness in endoscopy AI.

ENAD CADx is an AI-powered solution that detects lesions in real time during colonoscopy and classifies them into three categories—adenoma/neoplasm, hyperplastic polyp, and SSL—supporting more precise clinical decision-making.

This designation is expected to accelerate the adoption of endoscopy AI in the public healthcare sector, and Ainex will continue to advance its technology and clinical validation.

With ENAD already adopted by over 100 hospitals in Korea and 30+ institutions globally, we are committed to expanding the impact of AI-powered endoscopy worldwide.